Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Health-Care Hearing at U.S. High Court Set for March 26-28

Dec. 19 (Bloomberg) -- The U.S. Supreme Court said it will hear arguments on President Barack Obama’s health-care law over three days, from March 26 to March 28.

Releasing a schedule today that has few, if any, precedents in modern court history, the justices left room to expand the 5 1/2 hours they already allotted for argument. The high court generally hears arguments for a single hour in each case.

The first day will center on the Anti-Injunction Act, a law that one federal appeals court concluded prevents judges from ruling until 2015 on the requirement -- also known as the individual mandate -- that Americans either buy insurance or pay a penalty.

The justices will use the second day of the hearings to consider the central issue: the constitutionality of the individual mandate. A group of 26 states, led by Florida, is among those challenging the provision.

On day three, the court will hear arguments on whether other parts of the law should be invalidated along with the individual mandate. The justices also will consider the states’ challenge to a provision expanding the Medicaid program for the poor.

The cases are National Federation of Independent Business v. Sebelius, 11-393; Department of Health and Human Services v. Florida, 11-398; and Florida v. Department of Health and Human Services, 11-400.

To contact the reporter on this story: Greg Stohr in Washington at gstohr@bloomberg.net.

To contact the editor responsible for this story: Mark Silva at msilva34@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.